{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:00:40Z","timestamp":1782252040435,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/ftd.0b013e318296a2ff","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T09:16:53Z","timestamp":1385025413000},"page":"816-822","source":"Crossref","is-referenced-by-count":26,"title":["Therapeutic Drug Monitoring of Psychotropic Drugs in China"],"prefix":"10.1097","volume":"35","author":[{"given":"Wei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-lang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Biao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":". AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0193-953X(18)30167-9","article-title":"Therapeutic drug monitoring. Principles and practice.","volume":"16","author":"Preskorn","year":"1993","journal-title":"Psychiatr Clin North Am"},{"key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.pra.0000336757.42437.fe","article-title":"Practical application of therapeutic drug monitoring: a tale of two patients.","volume":"14","author":"Preskorn","year":"2008","journal-title":"J Psychiatr Pract"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00228-007-0430-1","article-title":"Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry.","volume":"64","author":"Hiemke","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"issue":"suppl 1","key":"R5-11-20210129","first-page":"21","article-title":"Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises Eur Arch Psychiatry Clin Neurosci.","volume":"258","author":"Hiemke","year":"2008","journal-title":""},{"key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1515\/CCLM.2004.243","article-title":"Therapeutic drug monitoring of non-tricyclic antidepressant drugs.","volume":"42","author":"Mitchell","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R7-11-20210129","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0009-8981(61)90127-9","article-title":"The determination of lithium in serum during therapy with lithium salts.","volume":"6","author":"Helm","year":"1961","journal-title":"Clin Chim Acta"},{"key":"R8-11-20210129","first-page":"276","article-title":"The preliminary report of the lithium concentration in saliva and plasma of patients treated with lithium.","volume":"6","author":"Wang","year":"1980","journal-title":"Chin J Nerv Ment Dis"},{"key":"R9-11-20210129","first-page":"176","article-title":"Therapeutic Drug Monitoring of Psychotropic Drugs.","volume":"7","author":"Fu","year":"2007","journal-title":"Eval Anal Drug Use Hosp China"},{"key":"R10-11-20210129","first-page":"627","article-title":"Relationship among serum concentrations, doses and clinical responses of quetiapine fumarate in patients with schizophrenia.","volume":"8","author":"Guo","year":"2003","journal-title":"Chin J Clin Pharmacol Ther"},{"key":"R11-11-20210129","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00007691-199812000-00002","article-title":"Delivery of therapeutic drug monitoring services: survey of Australasian clinical pharmacology laboratories.","volume":"20","author":"Morris","year":"1998","journal-title":"Ther Drug Monit"},{"key":"R12-11-20210129","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00007691-199412000-00006","article-title":"Australian cyclosporin therapeutic monitoring method survey: 1993.","volume":"16","author":"Morris","year":"1994","journal-title":"Ther Drug Monit"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1469-0691.2004.00747.x","article-title":"The use and therapeutic drug monitoring of teicoplanin in the UK.","volume":"10","author":"Darley","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"R14-11-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-0031-1286281","article-title":". Therapeutic drug monitoring in Italian psychiatry.","volume":"44","author":"Conca","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R15-11-20210129","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.4045\/tidsskr.12.0383","article-title":". Therapeutic drug monitoring (TDM) repertoire in Norway.","volume":"132","author":"Westin","year":"2012","journal-title":"Tidsskr Nor Laegeforen"},{"key":"R18-11-20210129","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1542\/peds.2006-2199","article-title":"Interference by carbamazepine and oxcarbazepine with serum- and urine-screening assays for tricyclic antidepressants.","volume":"120","author":"Saidinejad","year":"2007","journal-title":"Pediatrics"},{"key":"R19-11-20210129","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/clinchem\/40.6.869","article-title":"Lithium determinations evaluated in eight analyzers.","volume":"40","author":"Sampson","year":"1994","journal-title":"Clin Chem"},{"key":"R20-11-20210129","first-page":"412","article-title":"Hekster YA, et al..","volume":"27","author":"Droste","year":"2005","journal-title":"TDM: therapeutic drug measuring or therapeutic drug monitoring Ther Drug Monit"},{"key":"R21-11-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-993224","article-title":". Clozapine in China.","volume":"41","author":"Tang","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"R22-11-20210129","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FTD.0b013e3181dad1fb","article-title":". Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.","volume":"32","author":"Couchman","year":"2010","journal-title":"Ther Drug Monit"},{"key":"R24-11-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2125.2007.02852.x","article-title":". Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.","volume":"64","author":"Tang","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"suppl l","key":"R25-11-20210129","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1007\/BF00442557","article-title":". Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age.","volume":"99","author":"Haring","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"R26-11-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00004850-200505000-00007","article-title":". An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levels.","volume":"20","author":"Ng","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"R27-11-20210129","first-page":"1081","article-title":". Serum concentration of clozapine between different ethnics.","volume":"05","author":"Yang","year":"2010","journal-title":"Chin Med"},{"key":"R28-11-20210129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425255.2012.657626","article-title":"Cytochrome P450 variations in different ethnic populations.","volume":"8","author":"Mcgraw","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e318296a2ff","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:41:06Z","timestamp":1620952866000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201312000-00011"}},"subtitle":["A Nationwide Survey"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e318296a2ff","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}